We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONEM
4276
DELISTED
1Life Healthcare
ONEM
-18,926
Closed -$332K
LHCG
4277
DELISTED
LHC Group LLC
LHCG
-7,907
Closed -$1.09M
ACDI.U
4278
DELISTED
Ascendant Digital Acquisition Corp. III Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
ACDI.U
-300,000
Closed -$3.04M
VLDR
4279
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
-93,595
Closed -$435K
GIACW
4280
CALL
DELISTED
Gesher I Acquisition Corp. Warrants
GIACW
-9,125
Closed -$92K
BNFT
4281
DELISTED
Benefitfocus, Inc.
BNFT
-53,062
Closed -$566K
SPNE
4282
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
-14,235
Closed -$194K
LJAQ
4283
DELISTED
LightJump Acquisition Corporation Common Stock
LJAQ
-5,525
Closed -$53K
PCSB
4284
DELISTED
PCSB Financial Corporation
PCSB
-1,735
Closed -$34K
LFG
4285
DELISTED
Archaea Energy Inc.
LFG
-870,147
Closed -$15.9M
ABMD
4286
DELISTED
Abiomed Inc
ABMD
-143,416
Closed -$51.5M
LOTZ
4287
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
-58,108
Closed -$132K
UPH
4288
DELISTED
UpHealth, Inc.
UPH
-7,072
Closed -$158K
FSRD
4289
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
-1,724,965
Closed -$17M
CYBE
4290
DELISTED
Cyberoptics Corp
CYBE
-9,987
Closed -$465K
PZN
4291
DELISTED
Pzena Investment Management, Inc. Class A
PZN
-4,853
Closed -$46K
HTAQ.U
4292
DELISTED
Hunt Companies Acquisition Corp. I Units, each consisting of one Class A ordinary share and one-half one redeemable warrant
HTAQ.U
-100,000
Closed -$1.01M
SRSA
4293
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
-1,294
Closed -$12K
TWTR
4294
CALL
DELISTED
Twitter, Inc.
TWTR
-114,100
Closed -$4.93M
TWTR
4295
PUT
DELISTED
Twitter, Inc.
TWTR
-600
Closed -$26K
MN
4296
DELISTED
MANNING & NAPIER, INC.
MN
-6,926
Closed -$57K
FMTX
4297
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
-4,631
Closed -$66K
RMO
4298
DELISTED
Romeo Power, Inc.
RMO
-105,528
Closed -$385K
EXTN
4299
DELISTED
Exterran Corporation
EXTN
-38,905
Closed -$116K
CNVY
4300
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
-6,597
Closed -$55K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.